Annual Report

Overview

The report presents SMS Pharmaceuticals' FY25 growth, with revenue of ₹783 Crore and continued expansion across global API markets. It highlights energy-efficiency investments, Zero Liquid Discharge facilities, water recycling, and green-chemistry initiatives. The company reports 1,470 employees, 42,146 training hours, and a focus on safety, inclusion, and professional development. A substantial Business Responsibility and Sustainability Report provides detailed environmental, workforce, human-rights, and governance disclosures.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024-2025
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services